Issue 3/2008
Content (175 Articles)
A New Option for Therapeutic Management of Patients with Cerebrovascular Disease
Massimo Volpe
The Clinical Significance of Blood Pressure Lowering Treatment: First-Line Drug Choice is Important
Luis M. Ruilope
The Clinical Significance of Blood Pressure Lowering Treatment: Is First-Line Drug Choice Important?
Guido Grassi
Is Renin-Based Treatment a Reasonable Strategy to Treat Essential Hypertension?
Andrea Verhovez, Paolo Mulatero, Chiara Bertello, Elisa Saglio, Andrea Viola, Francesco Tosello, Franco Rabbia, Franco Veglio
Coronary Flow Reserve and Small Artery Remodelling in Hypertensive Patients
Damiano Rizzoni, Carlo Palombo, Enzo Porteri, Maria Lorenza Muiesan, Michaela Kozàkovà, Massimo Salvetti, Carmela Morizzo, Carolina De Ciuceis, Eugenia Belotti, Enrico Agabiti Rosei
Is C-Reactive Protein a Reliable Risk Factor of Cardiovascular Morbidity and Mortality in Clinical Practice?
Luigi Vernaglione, Viviana Nosella, Stefano Chimienti
Arterial Hypertension and Cardiac Damage
Enrico Agabiti Rosei, Giovanni de Simone, Gianfrancesco Mureddu, Bruno Trimarco, Paolo Verdecchia, Massimo Volpe
1.2 Comparison Between CRP and Other Conventional Risk Factors on Arterial Stiffness in Treated Essential Hypertension
C. Giannattasio, M. Failla, P. Campadello, P. Canova, M. Alloni, M. Galbiati, F. Citterio, G. Grosso, D. Dozio, F. Madotto, A. Capra, G. Mancia
1.1 Platelet Activation and Cognitive Impairment in Elderly Patients with Metabolic Syndrome
G. Desideri, D. Grassi, R. Bocale, R. Scipioni, S. Necozione, G. Croce, S. Tiberti, G. Mauti, C. Ferri
1.3 Renal Angioplasty Reduces Leukocytes Count in Hypertensive Patients with Atherosclerotic Renal Artery Stenosis
A. Morganti, B. Gidaro, C. Lonati
1.4 Manidipine Inhibits the Release of Interleukin-6 (Il-6) Induced by Modified Lipoprotein and by TNF-Alpha in Culture Human Endothelial Cells
S. Costa, M. Pedrelli, N. Ronda, M. Adorni, F. Bernini, G. Cremonesi
1.5 Brisighella Heart Study: Hypertension, HDL Cholesterol and Triglycerides
S. D’Addato, E. Tartagni, A. Dormi, L. Laghi, M. Rosticci, E. Kaio, C. Borghi
1.6 Brisighella Heart Study (BHS): Hypertension and Lipidic Parameters
S. D’Addato, A. Dormi, L. Laghi, E. Tartagni, F. Imola, M. Rosticci, C. Borghi
1.7 Carotid Intima-Media Thickness and Prevalence of Plaques in Patients with Primary Aldosteronism and With Essential Hypertension
M. Salvetti, M.L. Muiesan, A. Paini, C. Agabiti-Rosei, C. Aggiusti, L. Micheletti, C. Monteduro, F. Marino, F. Bertacchini, D. Rizzoni, E. Porteri, E. Agabiti-Rosei
1.8 A Functional LDL Receptor-Related Protein 6 Gene Variant is an Independent Risk Factor For Early Carotid Artery Atherosclerosis in Hypertensive Patients
R. Sarzani, F. Salvi, M. Bordicchia, F. Guerra, I. Battistoni, L. Roberti, M. Fortunati, P. Dessì-Fulgheri, A. Rappelli
1.9 Circulating Vascular Endothelial Growth Factor and Cell Adhesion Molecule Levels are Increased In ‘Non-Dipper’ Patients
I. De Roma, R. Ria, V. Longo, G. Ranieri
1.10 Superiority of Apolipoproteins Compared to Non-HDL Cholesterol in Predicting the Presence of Coronary Disease in Hypertensive Patients with Ischemic Heart Disease
F. Paneni, S. Sciarretta, A. Ricotta, F. Marrara, F. Palano, G. Tocci, M. Testa, M. Volpe
1.11 Prevalence of Metabolic Alterations In Hypertensive Patients with Stable vs Unstable Angina
F. Paneni, S. Sciarretta, A. Ricotta, F. Marrara, F. Palano, G. Tocci, M. Testa, M. Volpe
1.12 C-Reactive Protein is Associated with Aortic Stiffness Independently of Microalbuminuria in Essential Hypertension
G. Mule’, S. Cottone, P. Cusimano, A. Palermo, E. Nardi, C. Geraci, A. Re, T. Bellavia, G. Cerasola
2.1 Blood Pressure Fall Overestimates the Association with the Vascular Damage, if not Adjusted for the Real Sleep Time
P. Nazzaro, G. Schirosi, V. Lucivero, V. Vulpis, M. Sancilio, A.M. Pirrelli, A. Tinelli, F. Federico
2.2 Reverse Dipping Blood Pressure Pattern is Characterized by a Marked Adrenergic Overdrive
G. Seravalle, R. Dell’Oro, F. Quarti-Trevano, F. Arenare, A. Rozzoni, V. Vella, L. Magni, C. Cuspidi, G. Grassi, G. Mancia
2.3 New-Onset Diabetes Mellitus and Impaired Fasting Glucose in White Coat, Masked And Sustained Hypertension: the PAMELA Study
M. Bombelli, H. Polo Friz, F. Ganz, R. Sanvito, F. Quarti-Trevano, D. Fodri, E. Toso, L. Primitz, M. Rondinelli, R. Facchetti, G. Grassi, R. Sega, G. Mancia
2.4 White Coat and Masked Hypertension Increase the Risk of New Onset Sustained Hypertension in the General Population
M. Bombelli, H. Polo Friz, F. Ganz, S. Buzzi, I. Ronchi, E. Toso, R. Sanvito, D. Fodri, L. Beltrame, L. Primitz, F. Quarti-Trevano, R. Facchetti, G. Grassi, R. Sega, G. Mancia
2.5 Correlation between Central Obesity and Nocturnal Hypertension in a female population
M.C. Bravi, C. Capristo, M. Compagnucci, L. Gasbardone
2.6 Proposal of a New Index and Criteria for Evaluation in Ambulatory Blood Pressure Monitoring
G. Malgieri, R. Battista, M. Ciaburri, C. Santoro
2.7 Ambulatory Arterial Stiffness Index and Cardiovascular Risk in a Sample of Hypertensive Adult Population
L. D’Elia, R. Ippolito, D. De Palma, G. Rossi, P. Schiattarella, M. Versiero, P. Strazzullo, F. Galletti
2.8 In Patients with Isolated Ambulatory Hypertension Central Blood Pressure and Augmentation Index are Increased: the VOBARNO Study
A. Paini, ML. Muiesan, M. Salvetti, E. Belotti, G. Galbassini, C. Agabiti-Rosei, C. Aggiusti, L. Micheletti, F. Marino, F. Bertacchini, E. Agabiti-Rosei
3.1 Genetics of Cardiovascular Risk in the Elderly: the ROVIGO study (Risk of Vascular Complication: Impact of Genetics in Old People)
A. Mazza, S. Zamboni, A. Marcolongo, E. Casiglia, A.C. Pessina, P. Rempelou, A. Bascelli, V. Tikhonoff, S. Cuppini
3.2 Cardiometabolic Prevention Project (PRECAM) in a Tuscany Population
S. Lenti, P. Borgheresi, L. Ghiadoni, S. Taddei, C. Nozzoli
3.3 Role of a Specialist Hospital Centre In Hypertensive Patients Risk Stratification
M. Crippa, S. Ettori, R. Costa, F. Zani, F. Del Magro, S. Camanini, G. Zanolini, R. Fariello
3.4 Fat Distribution and Cardiovascular Risk in Obese Women
G. Salvetti, F. Santini, A. Pucci, D. Versari, A. Virdis, P. Fierabracci, G. Scartabelli, G. Querci, A. Tamberi, A. Pinchera, A. Salvetti
3.5 Prevalence of Hypertension and Urinary Abnormalities in an Indian Paediatric Population
A. Aiello, M. Gallieni, M. Giussani, S.K. Brahmochary Mandal, F. Pieruzzi, A. Stella, S. Genovesi
3.6 Sodium Intake in a Sample of Males Working in Campania: Results of the Olivetti Heart Study
A. Venezia, G. Barba, F. Galletti, E. Farinaro, A. Barbato, L. D’Elia, R. Ippolito, D. De Palma, P. Strazzullo
3.7 Hypertension and Impaired Carbohydrate Tolerance
E. Colli, R. Pedrazzoli, S. Onolfo, E. Scaglia, G.P. Carnevale Schianca, E. Bartoli
3.8 Consensus Document on Diagnosis and Clinical Management of Obstructive Sleep Apnoea in Hypertensive Patients
C. Lombardi, G. Mancia, M. Bartesaghi, A. Giuliano, G. Parati
3.9 Point of Care Testing of Cholesterol and Triglycerides In Epidemiological Studies: Evaluation of the MultiCare System
S. Rapi, V. Sbolci, C. Bazzini, C. Tozzetti, P.A. Modesti
3.10 Assessment of Pulse Wave Velocity and Cardiovascular Risk Stratification in a General Population: the Vobarno Study
M. Salvetti, ML. Muiesan, A. Paini, C. Monteduro, E. Belotti, C. Corbellini, G. Galbassini, C. Agabiti-Rosei, L. Micheletti, C. Aggiusti, F. Marino, F. Bertacchini, E. Agabiti-Rosei
3.11 Daily Activities in Hypertensive Elderly People Affected by Diabetes Mellitus Type II
F. D’Amico
3.12 Angiotensin II Receptor Blockers and Risk of Myocardial Infarction: a Meta-Analysis of Randomized Clinical Trials Updated Until May 1, 2008
M. Volpe, G. Tocci, B. Trimarco, G. Mancia
4.1 The B Allele of the BsmI Vitamin D Receptor (VDR) Gene Polymorphism is Independently Associated to LVH and to Higher Progression Rate of LVH in End-Stage Renal Disease (ESRD) Patients
A. Testa, F. Mallamaci, F. Benedetto, A. Pisano, G. Tripepi, L.S. Malatino, C. Zoccali
4.2 Chromosome 2q12: the Adrenergic Receptor 2b (ADRA2b) Gene and Metabolic Syndrome in Swedish — is there a Link?
C. Fava, M. Montagnana, P. Almgren, P. Burri, F. VonWowern, A. Lechi, O. Melander
4.3 The V433M Variant of the CYP4F2 is Associated with Ischemic Stroke in Male Swedish Beyond its Effect on Blood Pressure
C. Fava, M. Montagnana, P. Almgren, P. Minuz, A. Lechi, O. Melander
4.4 Correlation Between NCX1 Polymorphisms and Therapy-Resistant Essential Hypertension
V. Trimarco, R. Giudice, L. Lardo, M. Marino, R. Izzo, A. Vasta, C.S. Cimmino, G. Di Renzo, L. Annunziato, N. De Luca
4.5 Linkage of Familial Hyperaldosteronism Type II at Chromosome 7p22 in Two Italian Families
P. Mulatero, N. Sukor, C. Bertello, R.D. Gordon, A. So, D. Duffy, L. Kelemen, Y. Jeske, F. Veglio, M. Stowasser
4.6 Angiotensinogen Promoter Variants and Tissue-Specific Regulation of Angiotensinogen Expression in Human Kidney and Visceral Adipose Tissue
R. Sarzani, M. Bordicchia, P. Dessì-Fulgheri, D. Minardi, G. Muzzonigro, A. Rappelli
4.7 Heritability of Plasma Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): a New Marker of Cardiovascular Risk
L. Lenzini, B. Caroccia, K. Antezza, R. Wolfert, R. Szczech, M. Cesari, K. Narkiewicz, C. Williams, G. Rossi
5.1 Cardiac Natriuretic Peptides Reflect Left Atrial Volume (LAV) and Capture Longitudinal Changes in LAV in End-Stage Renal Disease Patients
G. Tripepi, F.A. Benedetto, F. Mallamaci, L.S. Malatino, C. Zoccali
5.2 Myocardial Integrated Backscatter in Normotensive and Hypertensive Diabetic Patients
A.C.M. Capra, C. Giannattasio, L. Viscardi, F. Soriano, F. Papalettera, P. Canova, P. Campadello, D. Dozio, A. Cafro, F. Paleari, G. Mancia
5.3 Left Ventricular Mass Independently Contributes to Long-Term Risk of Cardiovascular Morbidity and Mortality in a General Population: Data From the PAMELA Study
M. Bombelli, R. Sanvito, D. Fodri, E. Toso, H. Polo Friz, L. Primitz, A. Casati, F. Ganz, F. Quarti-Trevano, S. Buzzi, S. Carugo, R. Facchetti, G. Grassi, R. Sega, G. Mancia
5.4 Studies on Left Ventricular Hypertrophy Regression in Arterial Hypertension: A Clear Message For The Clinician?
V. Giudici, C. Cuspidi, A. Esposito, F. Negri, C. Sala, M. Maisaidi, A. Zanchetti, G. Mancia
5.5 Prevalence and Correlates of Multiple Organ Damage in Treated Hypertensives: Results From the ETODH Study
C. Cuspidi, C. Valerio, C. Cuspidi, F. Negri, V. Giudici, C. Sala, M. Maisaidi, A. Zanchetti, G. Mancia
5.6 The HYPERPRACT Study: a Multicentre Survey on the Accuracy of the Echocardiographic Assessment of Hypertensive Left Ventricular Hypertrophy In Clinical Practice
C. Cuspidi, M. Maisaidi, F. Negri, C. Cuspidi, C. Valerio, V. Giudici, C. Sala, M.L. Muiesan, A.M. Grandi, G. Palombo, C. Pini, A. Zanchetti, G. Mancia
5.7 The Input of Home Telemonitoring for the Treatment of Chronic Heart Failure in Old People at High Risk
M. Benvenuto, L. Beltrami, C. Redaelli, D. Solari, M. Pozzi, G. Rossetti, S. Carugo
5.8 Aspects of Post-Exercise Recovery in Young Hypertensives Borderline
G. Ratti, C. Elettrico, F. Buono, G. Covino, P. Tammaro, C. Fulgione, D. Buono, F. Borrelli, C. Tedeschi, P. Capogrosso
5.9 Left Ventricular Asymmetry in Hypertension: Effects on the QT Dispersion
G. Ratti, F. Buono, C. Fulgione, C. Tedeschi, G. Covino, P. Tammaro, G. Ricciardi, M. Volpicelli, F. Borrelli, P. Capogrosso
5.10 Paracetamol Increases 24-Hour Blood Pressure and Heart Rate in Patients with Stable Coronary Artery Disease
I. Sudano, A.J. Flammer, D. Periàt, F. Enseleit, M. Hermann, A. Hirt, P. Kaiser, T.F. Luscher, R. Corti, G. Noll, F. Ruschitzka
5.11 ‘Raffaello Project’: Application of the ‘Disease and Care Management’ Approach in Cardiovascular Disease Prevention
A. Rappelli, M. Penco, S. Romano, G. Perna, A. Musilli, F. Di Stanislao, M. Fratini, F. Mascella, M. Belligoni, A. Deales
5.12 Echocardiographic Study with Tissue Velocity and Strain Imaging Evaluation on the Effects of Exercise Training on Systo-Diastolic Ventricular Dysfunction In Patients With Hypertension
M. Leggio, L. Sgorbini, G. Cruciani, G.R. Cristinziani, A. Mazza, M.G. Bendini, F. Leggio, A.P. Jesi
5.13 Arterial Hypertension and Hyperhomocysteinaemia with TT Polymorphism of the C677T Gene for the 5-10-Methylenetetrahydrofolate Reductase: Risk Factors able to influence Clinical Management of the Patent Foramen Ovale?
A. Mazza, S. Zamboni, S. Cuppini, M. Armigliato, P. Rempelou, A. Camerotto, M. Gusella, A.C. Pessina, V. Tikhonoff, E. Casiglia
5.14 Obesity-Related Adjunctive Systo-Diastolic Ventricular Dysfunction in Patients with Hypertension: Echocardiographic Evaluation with Tissue Velocity and Strain Imaging
M. Leggio, L. Sgorbini, G. Cruciani, G.R. Cristinziani, A. Mazza, M.G. Bendini, F. Leggio, A.P. Jesi
5.15 Left Ventricular Patterns in a Population of a Hypertension Centre Echolab
D. Degli Esposti, A. Dormi, S. Bacchelli, E.R. Cosentino, F. Santi, E.R. Rinaldi, M. Rosticci, M. Pombeni, D. Maione, E. Tartagni, M. Veronesi, C. Borghi
5.16 Left Ventricular Geometry In Chronic Kidney Disease
E. Nardi, A. Palermo, G. Mulè, P. Cusimano, S. Cottone, A. Re, T. Bellavia, G. Cerasola
5.17 Effects of Chronic Angiotensin II Administration on MicroRNA Expression in Rat Cardiovascular System
G. Castoldi, C. di Gioia, C. Bombardi, M. Mancini, M. Leopizzi, B. Corradi, G. Zerbini, A. Stella
5.18 Cardiovascular and Metabolic Predictors of Progression to Overt Hypertension in a Population with Basal High-Normal Blood Pressure Levels: The Strong Heart Study
M. De Marco, M. Chinali, M.J. Roman, E.T. Lee, M. Russell, B.V. Howard, G. de Simone, R.B. Devereux
5.19 Correlation Among Renal and Cardiac Function and Left Ventricular Geometries: The Strong Heart Study
M. De Marco, G. de Simone, M. Chinali, M.J. Roman, E.T. Lee, M. Russell, N. Shara, R.B. Devereux
5.20 Metabolic Syndrome and Obstructive Sleep Apnoea In Patients with Visceral Obesity: Effect on Left Ventricular Remodelling
A.M. Maresca, A.M. Grandi, E. Laurita, F. Colombo, F. Solbiati, D. Abernasconi, M. Marogna, C. Salina, E. Nicolini, C. Mongiardi, F. Avenco
5.21 Blood Pressure Levels, Left Ventricular Mass and Function are correlated with Left Atrial Volume in Mild to Moderate Hypertensive Patients
A. Milan, S. Delcolle, M. Caserta, D. Naso, C. Magnino, E. Puglisi, F. Tosello, A. Viola, F. Veglio
5.22 Correlation Between Parameters of Non-invasive Haemodynamic Monitoring, Levels of Natriuretic Peptides and Echocardiographic Indexes of Diastolic Dysfunction in Chronic Systolic Heart Failure
G. Branzi, G. Malfatto, S. Blengino, A. Giglio, C. Facchini, M. Facchini, G. Parati
5.23 Determinants of Left Ventricular Mass (LVM) in White Obese Women
G. Salvetti, F. Santini, A. Pucci, D. Versari, A. Virdis, P. Fierabracci, G. Scartabelli, C. Palagi, V. Di Bello, A. Pinchera, A. Salvetti
5.24 Obesity Increases the Effect of Sodium Intake on Left Ventricular Mass in Hypertensive Patients
R. Sarzani, F. Salvi, L. Angelini, I. Ciccarelli, M. Fortunati, E. Nicolini, G. Refi, P. Dessì-Fulgheri, A. Rappelli
5.25 Green Tea Extracts Prevent Development of Cardiac Fibrosis in Angiotensin II-Dependent Hypertension by Blunting Oxidative Stress
M. Seccia, A.S. Belloni, M. Antonello, A. Sandri, D. Guidolin, A.C. Pessina, G.P. Rossi
5.26 Left Ventricular Hypertrophy Prevalence by Different Left Ventricular Mass Indexes
D. Degli Esposti, A. Dormi, S. Bacchelli, E.R. Cosentino, F. Santi), M. Rosticci, E.R. Rinaldi, M. Pombeni, E. Tartagni, V. Immordino, M.G. Prandin, L. Laghi, C. Borghi
5.27 Metabolic Syndrome and Multiple Organ Damage in Essential Hypertension
C. Cuspidi, C. Valerio, V. Giudici, F. Negri, C. Sala, M. Maisaidi, A. Zanchetti, G. Mancia
6.1 Hypertension Associated with Obesity or Overweight: a Role for Aldosterone?
G.P. Rossi, A. Belfiore, G.P. Bernini, B. Fabris, G. Caridi, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, M. Mannelli, G. Palumbo, A. Patalano, D. Rizzoni, A.C. Pessina, F. Mantero
6.2 Comparison of Three Different Doses of ACTH Stimulation During Adrenal Vein Sampling (AVS) in the Work-Up of Primary Aldosteronism
M. Seccia, D. Miotto, F. Mantero, G. Pitter, A. Patalano, A.C. Pessina, G.P. Rossi
6.3 Pheochromocytoma: Clinical, Diagnostic and Genetic Aspects: Experience in a Single Centre
D. Cotesta, L. Petramala, G. De Toma, A. Verrienti, S. Filetti, C. Letizia
6.4 Cardiac Modifications in Patients with Primary Aldosteronism Before and After Specific Treatment
L. Petramala, D. Cotesta, L. Zinnamosca, C. Letizia, G. Iacobellis
6.5 Silent Pheochromocytoma Presenting as Tako-Tsubo Syndrome during Anaesthesiological Stress
E. Malshi, C. Palombo, G. Bernini, A. Bacca, S. Lavorini, P. Berti, C. Materazzi, F. Giunta, F. Forfori, A. Salvetti
6.6 Polycystic Ovary Syndrome: Implications of Aldosterone and Progesterone Values in the Different Phases of the Cycle
S. Garelli, C. Fiore, A. Andrisani, F. Manganello, S. Cavaliere, D. Pellati, D. Faggian, M. Plebani, G. Ambrosini, D. Armanini
6.7 A Case of Left Ventricular Ballooning ‘Takotsubo Syndrome’ Associated with Pheochromocytoma
D. Cotesta, C. Letizia, L. Petramala, A. Verrienti, S. Filetti, S. Volpe, C. Greco
6.8 Application of a New Chemiluminescent Method for Direct Renin Measurement to the Calculation of Aldosterone/Renin Ratio in Patients with Essential Hypertension
C. Lonati, A. Gritti, B. Gidaro, A. Morganti
6.9 Plasma Aldosterone and Albumin Urinary Excretion in Hypertension
G.L. Colussi, C. Catena, A. Chiuch, E. Nadalini, A. Di Fabio, L. Sechi
6.10 Primary Hyperaldosteronism Treatment Reduces Left Ventricular Mass According to the Entity of Hormonal Production
C. Catena, G.L. Colussi, A. Chiuch, E. Nadalini, A. Di Fabio, W. Bragagnini, M. Valeri, L. Sechi
6.11 Prevalence of Glycaemic Alteration in Hypertensive Subjects with Cardiac Hypertrophy
R. Pedrazzoli, S. Onolfo, E. Colli, E. Scaglia, G.P. Carnevale, E. Bartoli
6.12 Long-Term Effects of Pharmacological and Surgical Treatment on Cardiovascular Parameters in Patients with Primary Aldosteronism
G. Bernini, R. Pisano, M. Bardini, C. Taurino, S. Lavorini, A. Bacca, C. Materazzi, A. Salvetti
6.13 Correlation Between TSH and Blood Pressure and Thyroid Diseases Prevalence in a Cohort of Patients with Primary Aldosteronism
F. Turchi, V. Ronconi, A. Taccaliti, M. Boscaro, G. Giacchetti
6.14 Activation of the Renin-Angiotensin-Aldosterone System during Drospirenone Administration for Contraception
E. Porteri, S. Paiardi, N. Rizzardi, C. Platto, C. De Ciuceis, G.E.M. Boari, F. Zani, D. Rizzoni, E. Agabiti Rosei
6.15 Roles of Clinical Criteria, CT Scan and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism Subtypes
P. Mulatero, C. Bertello, D. Rossato, G. Mengozzi, A. Milan, A. Viola, F. Tosello, F. Rabbia, F. Veglio
6.16 Rapid Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism
P. Mulatero, C. Bertello, G. Mengozzi, D. Rossato, A. Milan, A. Viola, F. Tosello, F. Rabbia, F. Veglio
6.17 Late Identification of a Tumour of the Juxta-Glomerular Apparatus (TJGA) in a Case of Longstanding Severe High-Renin Hypertension and Hypokalaemia
G. Regolisti, A. Cabassi, E. Parenti, C. Maccari, P. Greco, A. Borghetti, E. Fiaccadori
7.1 Left Ventricular Strain in Subjects Affected from Arterial Hypertension
A. Pierini, F. Magrini, B. Abdel Ghani
7.2 Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients during Anti-Hypertensive Treatment: the Life Study
M. Chinali, G. de Simone, G.P. Aurigemma, R.K. Mishra, E. Gerdts, K. Wachtell, K. Boman, B. Dahlöf, R.B. Devereux
7.3 Association of Carotid Artery Stiffness Assessed with E-Tracking and Diastolic Dysfunction Assessed with Tissue Doppler Imaging Inpatients with Masked Hypertension
F. Natale, C. Siniscalchi, L. Aronne, M. Credendino, R. Mocerino, G. Tassinario, V. De Simone, L. Di Scotto Tella, S. Morraò, P. Calabrò, M.A. Tedesco, R. Calabrò
7.4 Early Cardiac Damage in High Cardiovascular Risk Patients
A.C.M Capra, M. Galderisi, C. Giannattasio, D. Dozio, P. Canova, F. Soriano, P. Innelli, A.A. Turco, S. Turco, P. Campadello, F. Paleari, O. De Divitiis, G. Mancia
8.1 Factors Associated With Renal Dysfunction In Arterial Hypertension: The REDHY Study
G. Cerasola, G. Mule−, S. Cottone, E. Nardi, P. Cusimano, R. Arsena, A. Palermo, M. Guarneri
8.2 Glomerular Filtration Rate by Creatinine and Cystatin C Measurements in Essential Hypertensive Patients
S. Cottone, M. Guarneri, R. Riccobene, F. Tornese, G. Giammarresi, C. Canale, G. Cerasola, R. Arsena
8.3 Which is the Best Cut-Off for the Definition of Microalbuminuria Using a Timed Urine Collection? Results in an Adult Sample of Male Population
A. Barbato, F. Galletti, L. D−Elia, R. Ippolito, P. Schiattarella, S. Avallone, A. Venezia, R. Iacone, M. Versiero, O. Russo, D. De Palma, P. Strazzullo
8.4 Circulating Levels of E-Selectin are Inversely Related to Left Ventricular Wall Thickness in Patients on Regular Dialysis
B. Stancanelli, A. Cataliotti, I. Bellanuova, F. Mallamaci, G. Tripepi, F.A. Benedetto, P. Fatuzzo, F. Rapisarda, D. Leonardis, C. Zoccali, L.S. Malatino
9.1 Pro-Arrhythmogenic Role of Sympathetic Activation and Baroreflex Dysfunction in Human Obesity
F. Arenare, G. Seravalle, R. Dell’Oro, M. Volpe, V. Ilardo, GM. Brambilla, G.B. Bolla, G. Grassi, G. Mancia
9.2 Increased Target Organ Damage in Subjects with Metabolic Syndrome but no Overt Cardiovascular Risk
D. Grassi, C. Lippi, S. Necozione, M. Michetti, A. D’Aurelio, L. Petrazzi, L. Polidoro, R. Scipioni, G. Properzi, G. Desideri, C. Ferri
9.3 Non-alcoholic Fatty Liver Disease, Adiponectin and Insulin-Resistance In Dipper And Non-Dipper Essential Hypertensive Patients
F. Fallo, A. Dalla Pozza, N. Sonino, G. Federspil, M. Ermani, S. Caroselli, C. Catena, G. Soardo, R. Carretta, D. Belgrado, B. Fabris, L. Sechi
9.4 Reproducibility Patterns of Plasma Noradrenaline and Muscle Sympathetic Nerve Traffic In Human Obesity
F. Quarti-Trevano, R. Dell’Oro, G. Seravalle, F. Arenare, G. Brambilla, V. Ilardo, L. Magni, G. Grassi, G. Mancia
9.5 Impact of Antihypertensive Treatment on Long-Term Risk of Diabetes Mellitus in a General Population Setting: Data from the PAMELA Study
M. Bombelli, M. Rondinelli, R. Sanvito, D. Fodri, E. Toso, H. Polo Friz, A. Casati, L. Primitz, F. Ganz, S. Buzzi, F. Quarti-Trevano, G. Grassi, R. Sega, G. Mancia
9.6 Which Antihypertensive Drugs in the Metabolic Syndrome?
A.M. Carella, G. Antonucci, M. Di Pumpo, E. Antonucci
9.7 Insulin-Resistance and Altered Circadian Blood Pressure Profile in Normotensive Young Women with Polycystic Ovary Syndrome
R. Mioni, N. Xamin, L. Zuliani, A. Belligoli, A. Pierobon, L. Bleve, M. Granzotto, P. Maffei, N. Sicolo, R. Vettor, F. Fallo
9.8 New-Onset Diabetes and Uncontrolled Blood Pressure
R. Izzo, G. de Simone, M. Chinali, R. Giudice, A. Vasta, I. Botta, C.S. Cimmino, S. Crispo, N. De Luca, B. Trimarco
9.9 Role of the Different Components of Metabolic Syndrome in the Pathogenesis of Adrenergic Overdrive
F. Quarti-Trevano, G. Seravalle, F. Arenare, V. Vella, M. Volpe, A. Rozzoni, R. Facchetti, M. Bombelli, G. Grassi, G. Mancia
9.10 Prognostic Relevance of Masked Hypertension in Subjects with Normal and High-Normal Clinic Blood Pressure
S.D. Pierdomenico, G. Pannarale, F. Rabbia, D. Lapenna, R. Licitra, M. Zito, M. Campanella, C. Gaudio, F. Veglio, F. Cuccurullo
9.11 Association between Plasma Aldosterone, Metabolic Syndrome and Left Ventricular Mass in Essential Hypertension
Giuseppe Mulè, Emilio Nardi, Paola Cusimano, Santina Cottone, Giovanna Seddio, Calogero Geraci, Alessandro Palermo, Anna Carola Foraci, Giovanni Cerasola
9.12 The Influence of Sex on the Relationships Between Metabolic Syndrome and Left Ventricular Mass in Hypertensive Patients
G. Mule’
9.13 Metabolic Alterations in Patients with Primary Aldosteronism (PA): Role of Adipokines
L. Petramala, G. Iacobellis, D. Cotesta, L. Zinnamosca, E. D’Erasmo, C. Letizia
9.14 Relation Between Resting Metabolic Rate and Blood Pressure in Overweight-Obese People: Effect of Gender
G. Seghieri, F. Cipollini, E. Arcangeli, G. Fabbri, I. Chiti, L. Fani, F. Franconi
9.15 Hypertension and Metabolic Syndrome after Liver Transplantations
Leoni, B. Stagni, E. Silvagni, C. Caprara, S. Flori, L. Bolondi
9.16 Hypertension Leads to Type 2 Diabetes Mellitus
S. Onolfo, R. Pedrazzoli, E. Colli, G.P. Carnevale Schianca, E. Bartoli
9.17 Influence of Non-Haemodynamic Factors on Left Ventricular Mass in Adolescents with High Prevalence of Obesity: the Strong Heart Study
M. Chinali, G. de Simone, M.J. Roman, E.T. Lee, L.G. Best, M. Russell, B.V. Howard, R.B. Devereux
9.18 Hypertension and Systemic Inflammation are Associated with Hyperleptinaemia Independently of Adiposity and Insulin Resistance
F. Galletti, L. De Lia, D. De Plama, R. Ippolito, O. Russo, R. Iacone, P. Strazzullo
9.19 Relationship of Serum Insulin, Leptin and Adiponectin and their Changes Over Time to the Incidence of Hypertension in Men: Results of the Olivetti Prospective Heart Study
S. Avallone, F. Galletti, R. Iacone, O. Russo, F.P. Cappuccio, A. Siani, A. Barbato, A. Venezia, M. Miller, R. Ippolito, P. Strazzullo
9.20 Hypertension, Obesity and Vascular and Renal Damage
N. Conti, F. Viazzi, G. Leoncini, E. Ratto, E. Baratto, G. Adami, F.S. Papadia, G. Deferrari, R. Pontremoli
9.21 Skin Fibroblasts Expression of PPAR-Gamma, At1 and At2 Receptors In Patients with Hypertension and Metabolic Syndrome: Preliminary
A.M. Maresca, A.M. Grandi, C. Mongiardi, P. Moretto, E. Nicolini, L. Montalbetti, A. Passi, A. Venco
9.22 A Human Fatty Acid Amide Hydrolase (FAAH) Functional Gene Variant Is Associated with Lower Blood Pressure in Young Males
R. Sarzani, M. Bordicchia, F. Salvi, G. Cola, E. Franchi, I. Battistoni, L. Mancinelli, A. Giovagnoli, P. Dessì-Fulgheri, A. Rappelli
9.23 The Metabolic Syndrome Early Exacerbates the Cerebral Vasodilatory Reactivity and the Microcirculatory Damage In Grade 1 Hypertensives
P. Nazzaro, V. Lucivero, G. Schirosi, M. Sancilio, M.P. Prontera, A. Tinelli, A.M. Pirrelli, F. Federico
9.24 Metabolic Syndrome and Acute Mountain Sickness
G. Strapazzon, A. Cogo, A. Semplicini
9.25 Evaluation of Appropriateness of Left Ventricular Mass in a Paediatric Population with Obesity
G. Tocci, A. Ferrucci, F. Ianniello, M. Evangelisti, A. Alterio, S. Sciarretta, F. Paneni, A. Macari, G.M. Ciavarella, L. De Biase, M.P. Villa, M. Volpe
9.26 Diagnosis of Metabolic Syndrome Based on History of Exposure or Present Abnormalities: Evidence of Necessity of a Better Definition
G. de Simone, R.B. Devereux, M. Chinali, D.C. Rao, S.C. Hunt, A. Kraja, D.K. Arnett
9.27 Metabolic Syndrome and Biventricular Hypertrophy in Essential Arterial Hypertension
C. Cuspidi
9.28 Metabolic Syndrome in Young Elderly: is a Natural Therapy Practicable?
A. Esposito, L. Beltrami, G. Rossetti, D. Solari, M.L. Rainoldi, G. Landi, S. Carugo
9.29 Diabetes and Incident Heart Failure: the Strong Heart Study
G. de Simone, R.B. Devereux, M. Chinali, E.T. Lee, J.M. Galloway, A. Barac, J. Panza, B.V. Howard
10.1 Sympathetic Responses to Ventricular Extrasystolic Beats in Obese Subjects without and with Sleep Apnoea
R. Dell’Oro, G. Seravalle, F. Quarti-Trevano, A. Rozzoni, M. Volpe, L. Magni, G. Grassi, G. Mancia
10.2 Baroreflex Sensitivity is Impaired in Post-Menopausal Women with Central Obesity
S. Del Colle, A. Milan, M. Caserta, A. Dematteis, D. Naso, C. Magnino, E. Puglisi, F. Tosello, A. Viola, A. Pertusio, F. Veglio
10.3 Inhibition of NO-Synthase Modulates Sympathetic Nervous Activity in hypertensive Patients
R.M. Bruno, I. Sudano, L. Ghiadoni, A. Magagna, S. Taddei, A. Salvetti
10.4 Acute Administration of Vitamin C Decreases Sympathetic Nervous Activity and Blood Pressure in Hypertensive Patients
R.M. Bruno, E. Daghini, L. Ghiadoni, I. Sudano, D. Versari, E. Duranti, A. Favilla, A. Magagna, S. Taddei, A. Salvetti
10.5 Blood Pressure and Cognitive Function in Elderly Patients with Diabetes Mellitus Type 2
F. D’Amico, A. Grippa
10.6 Spectral HRV Components and Pharmacological Treatment in Subjects with Syncope
G. Amen, G. Covi, S. Al Zeer, L. Fondrieschi, F. Paluani, A. Lechi, G. Amen
10.7 QT/RR Slope: a Novel Arrhythmogenic Substrate in Hypertensive Left Ventricular Hypertrophy
G. Schillaci, G. Pucci, M. Pirro, J. Helou, G. Vaudo, L. Pasqualini, E. Mannarino
11.1 Cost and Prescription of Antihypertensive Therapy in Region Lombardia Between 2004/2006: Fixed Combinations as Savings Opportunities
S. Carugo, A. Esposito, D. Solari, G. Rossetti, B. Cami, G. Mancia
11.2 The Appropriate Drugs Titration and the Optimization of the Therapy in Chronic Heart Failure (CHF): the Outcomes in our Experience of Home TelemonItoring (HTM)
L. Beltrami, M. Benvenuto, C. Redaelli, D. Solari, G. Rossetti, S. Pizzocri, S. Carugo
11.3 Ambulatory Monitoring of Blood Pressure (AMBP) in Young People with Obstructive Sleep Apnoea Syndrome (OSAS
R. Muschera’, M. D’avino, G. Caruso, E. Anastasio, D. Caruso, F. De Michele, R. Muschera’
11.4 Lifestyle Modifications in Hypertensives: Who Does it Matter?
D. Scala, S. Cozzolino, A. Mancini, M. D’avino, G. Caruso, R. Muschera’, G. Colucciello, V. Luciani, D. Caruso
11.5 Blood Pressure Control and Anti-Hypertensive Drugs in 490 Patients with Hypertension and Chronic Kidney Disease
Palermo, R. Arsena, C. Briolotta, P. Cusimano, M. Guarneri, R. Riccobene, G. Mulè, E. Nardi, F. Vaccaro, S. Cottone, G. Cerasola
11.6 Determinants of Resistant Hypertension in a Sample of Adult Male Population (8-Year Follow-Up)
A. Barbato, F. Galletti, L. D’Elia, R. Ippolito, P. Schiattarella, S. Avallone, R. Iacone, A. Venezia, M. Versiero, O. Russo, D. De Palma, P. Strazzullo
11.7 Lifestyle Modifications: a Very Good Weapon Against Hypertension
A. Di Patria, A. Lerro, M. Pietrosante, V. Del Villano
11.8 Addition of Canrenone to Optimal Therapy Improves Cardiac Geometry and Function in Patients with Systolic Heart Failure and Metabolic Syndrome: the AREA-IN-CHF Study
M. Chinali, G. de Simone, G.F. Mureddu, I. Botta, G. Cacciatore, M. Porcu, A.P. Maggioni, A. Boccanelli
11.9 Differences between ACE Inhibitor and Angiotensin II Receptor Blocker-based therapy in preventing myocardial infarction, stroke and cardiovascular mortality: a meta-analysis
G. Reboldi, F. Angeli, C. Cavallini, G. Gentile, G. Mancia, P. Verdecchia
11.10 Effects of Aggressive Treatment with Statins on Carotid Plaque: Use of Integrated Backscatter
M.A.E. Rao, R. Giudice, F. Rozza, S. Crispo, L. Lardo, A. Vasta, O. Arcucci, C.S. Cimmino, F.M. Esposito, G.L. Iovino, N. Deluca
11.11 Effect of Valsartan-Amlodipine Combination on Cognitive Function In Elderly Hypertensive Patients
R. Fogari, G. Derosa, P. Lazzari, A. Mugellini, P. Preti, R. Mereu, T. Santoro
11.12 Retinol Binding Protein (RBP-4) and Sympathetic Interaction in Overweight Hypertensives: Effect of Intensive Dietetic Treatment
A. Cabassi, G. Regolisti, E. Parenti, S. Tedeschi, E. Cremaschi, P. Greco, C. Maccari, S. Cavazzini, A. Bocchi, A. Borghetti, E. Fiaccadori
11.13 Utility of Determination of Plasma Renin Activity in Choosing the Antihypertensive Treatment
G. Leotta, F. Rabbia, P. Mulatero, E. Testa, E. Saglio, F. Tosello, A. Viola, F. Veglio
12.1 Enhanced Proatherogenic Inflammation After Recombinant Human TSH Administration in Patients Monitored for Thyroid Cancer Remnant
G. Desideri, R. Bocale, D. Milardi, L. Ghiadoni, D. Grassi, R. Scipioni, S. Necozione, G. Croce, S. Taddei, A. Pontecorvi, C. Ferri
12.2 Black Tea Dose-Dependently Improves Endothelial Function and Decreases Blood Pressure and Peripheral Arterial Stiffness in Healthy Males
D. Grassi, T.P.J. Mulder, R. Draijer, G. Desideri, H.O.F. Molhuizen, C. Ferri
12.3 Platelet Cyclic GMP Levels and the Aggregating Response to Adrenaline in Essential Hypertensive patients
C. Sala, M. Rescaldani, A. Morganti
12.4 Effects of Triglyceridaemia on Carotid Wall Thickness in Treated Essential Hypertension
C. Giannattasio, M. Failla, P. Campadello, D. Dozio, P. Canova, A. Cafro, E. Montemerlo, M. Rigoldi, E. Scanziani, I. Viscardi, F. Madotto, A. Capra, G. Mancia
12.5 Analysis of Endothelium-Dependent Dilation, Aortic Stiffness and Microcirculatory Flux in Achondroplastic Patients
S. De Marchi, A. Zambito, A. Rigoni, D. Bianchini, M. Prior, E. Arosio
12.6 Resistance Artery Remodelling in Young Spontaneously Hypertensive Rats is Prevented with Chronic Treatment with Heparin
G.E.M. Boari, P.M.H. Schiffers, G. Fazzi, D. Rizzoni, E. Agabiti Rosei, J.G. De Mey
12.7 Organ Culture is Not a Suitable Model to Study Angiotensin II-Induced Remodelling in Resistance-Sized Arteries of Spontaneously Hypertensive Rats (SHR)
G.E.M. Boari, N. Rizzardi, C. Platto, C. De Ciuceis, E. Porteri, S. Paiardi, D. Rizzoni, E. Agabiti Rosei
12.8 Endotelin-1 and 8-Isoprostanes Predict Estimated Glomerular Filtration Rate in Arterial Hypertension
S. Cottone, M. Guarneri, G. Mulè, R. Riccobene, MC. Lorito, E. Nardi, R. Arsena, A. Palermo, P. Cusimano, F. Vaccaro, F. Tornese, C. Canale, A. Vadalà, G. Cerasola
12.9 Arterial Stiffness and Endothelial Function in Relation to Left Ventricular Diastolic Dysfunction in Non-Ischaemic Heart Failure
F. Stea, L. Ghiadoni, S. Buralli, R.M. Bruno, F.L. Dini, S.M. De Tommasi, S. Taddei, A. Salvetti
12.10 Role of Sympathetic Activation on Changes of Brachial Artery Endothelial Function During Hyperinsulinaemia in Healthy Subjects
C. Morgantini, F. Stea, L. Ghiadoni, E. Duranti, S. Taddei, A. Natali, E. Ferrannini, A. Salvetti
12.11 Coronary Flow Reserve is Impaired in Uncomplicated Hypertensive Patients with Renal Dysfunction
N. Conti, F. Viazzi, GP. Bezante, G. Leoncini, E. Ratto, G. Deferrari, R. Pontremoli
12.12 Estimated GFR is Not Associated with Endothelium-Dependent and independent Vasodilation in the Brachial Artery
D. Versari, L. Ghiadoni, E. Daghini, R.M. Bruno, Y. Plantiga, G. Salvetti, A. Magagna, S. Taddei, A. Salvetti
12.13 Estimated GFR is Associated with Endothelium-Independent Vasodilation in the Forearm Microcirculation of Hypertensive Patients
D. Versari, A. Virdis, L. Ghiadoni, E. Daghini, S. Masi, A. Magagna, A. Salvetti, S. Taddei
12.14 Subcutaneous Small Resistance Artery Remodelling in Patients with Cushing’s Syndrome
C. De Ciuceis, E. Porteri, N. Rizzardi, C. Platto, S. Paiardi, G.E.M. Boari, G.A.M. Tiberio, S.M. Giulini, D. Rizzoni, E. Agabiti Rosei
12.15 Effect of Anti-Hypertensive Treatment on Circulating Endothelial Progenitor Cells in Patients with Mild Essential Hypertension
C. De Ciuceis, E. Porteri, D. Rizzoni, M.L. Muiesan, M. Salvetti, A. Paini, E. Belotti, F. Zani, G.E.M. Boari, E. Agabiti Rosei
12.16 Primary Aldosteronism and Endothelial Progenitor Cell Bioavailability
A. Verhovez, A. Zeoli, T.A. Williams, F. Morello, E. Saglio, A. Viola, F. Tosello, M.F. Brizzi, F. Veglio, P. Mulatero
12.17 Flow Dependent Vasodilation of Brachial Artery: Effect of Treatment with a Calcium Antagonist or Thiazide Diuretic in the Essential Hypertensive Patient
S.M. Salvetti, A. Paini, E. Belotti, C. Aggiusti, C. Agabiti-Rosei, F. Marino, F. Bertacchini, M.L. Muiesan, E. Agabiti-Rosei
12.18 Correlation between Ambulatory Arterial Stiffness Index (AASI) and Pulse Wave Velocity in a General Population: the Vobarno Study
A. Paini, M. Salvetti, C. Aggiusti, E. Belotti, G. Galbassini, C. Corbellini, C. Agabiti-Rosei, L. Micheletti, F. Bertacchini, F. Marino, M.L. Muiesan, E. Agabiti-Rosei
12.19 Evidence of a Relationship between Arterial Stiffness and Microcirculation in Hypertensive Patients
M.L. Muiesan, D. Rizzoni, M. Salvetti, A. Paini, C. De Ciuceis, C. Agabiti-Rosei, C. Aggiusti, L. Micheletti, E. Porteri, E. Agabiti-Rosei
12.20 Cardio Ankle Vascular Index (CAVI) is Related to Pulse Wave Velocity and Augmentation Index
A. Milan, F. Tosello, S. Delcolle, M. Caserta, D. Naso, E. Puglisi, C. Magnino, A. Viola, F. Veglio
12.21 Fructose, Endothelial Function and Vascular Reactivity in Isolated Rat Aorta
P. Kogoj, L. Ziberna, G. Drevenscek, I. Gilotta, E. Panizon, E. Bernobich, G. Bellini, A. Cosenzi
12.22 Sedentary Blood Pressure Variability is Associated with the Microvascular Damage in Normotensive Subjects
P. Nazzaro, V. Lucivero, V. Vulpis, G. Schirosi, M. Sancilio, M Bracciolini, A.M. Pirrelli, F. Federico
12.23 Relationship between Carotid Artery Stiffness Assessed with Etracking and Carotid Plaque Echogenity in Hypertensive Patients
F. Natale, L. Aronne, M. Credendino, R. Mocerino, C. Siniscalchi, G. Tassinario, V. De Simone, L. Di Scotto Tella, P. Calabrò, M.A. Tedesco, R. Calabrò
12.24 Coronary Intrastent Restenosis and Blood Pressure Levels: Retrospective Analysis of a Large Cohort of Patients with Coronary Single Vessel Disease
G. Tocci, R. Coluccia, A. Modestino, S. Sciarretta, F. Paneni, D.M. Zardi, B.A. Pace, C. Nannini, S. Abbolito, G. Sorropaco, A. Ferrucci, A. Berni, P. Rubino, M. Volpe
12.25 Aortic Stiffness: a Reversible Marker of Cardiovascular Risk in Primary Hyperparathyroidism?
G. Pucci, M.R. Mannarino, N. Avenia, M. Monacelli, G. Fabbriciani, M. Pirro, A.M. Scarponi, E. Mannarino, G. Schillaci
12.26 Is Brachial Artery Diameter an Early Index of Organ Damage in Hypertension?
G. Pucci, M.R. Mannarino, M. Pirro, J. Helou, G. Vaudo, E. Mannarino, G. Schillaci
12.27 Does Ambulatory Blood Pressure Monitoring Provide a Reliable Measure of Arterial Stiffness?
G. Schillaci, G. Pucci, M. Pirro, D. Hijazi, M.R. Mannarino, G. Vaudo, E. Mannarino